The Anatomical Record, the official organ of the American Association of Anatomists, weighs its acceptances on “the quality of the research, its originality and significance to our readership.”
So it’s not surprising that when it gets duped, it gets angry.
Consider the following retraction notice that appeared recently in the publication for an article it ran early 2010: Continue reading Correcting The Anatomical Record: Article pulled after former student lifted lab findings
A group of hematology researchers in Canada lost a publication to the merger of two medical device makers, after the acquiring company apparently decided not to pursue marketing the product in question.
An April 23 retraction notice in the International Journal of Laboratory Hematology about the article, “Enhanced flagging and improved clinical sensitivity on the new DxH 300TM Coulter® cellular analysis system,” originally published in February, tells the tale: Continue reading Assay come, assay go: Corporate takeover leads to retraction of device analysis
The Journal of Neurochemistry has retracted a 2008 paper, “Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury,” it had initially corrected — and how.
The correction, which appeared online in August 2010, was extensive: Continue reading Neurochemistry journal retracts paper after earlier mega-correction for an author who’s no stranger to errata
A group of researchers whose work has been under investigation at the University of Louisville has issued a correction for a paper in the American Journal of Respiratory Cell and Molecular Biology (AJRCMB).
The correction follows three retractions each in the Journal of Biological Chemistry and the AJRCMB, the latter of which made it clear that lab member ShouWei Han was responsible for the manipulations and duplications that brought down the papers. Here’s the new notice, which appeared in the March 1, 2012 issue of the journal: Continue reading Group investigated by University of Louisville corrects lung cancer paper after retracting six others
The Journal of Clinical Investigation has retracted a 2010 article after the researchers acknowledged that the paper contained a substantial amount of manipulated or manufactured data.
How much bad data? Enough to sink seven figures. And the authors said they could not produce raw data in another 19 or so figures and four tables.
But, as the notice states, the researcher said that despite the retraction, they stand by the thrust of their article, “Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice:” Continue reading It’s all bad, it’s all good: JCI retracts for made-up data but authors stand behind work
Shigeaki Kato, an endocrinology researcher at the University of Tokyo who retracted a paper late last month, has resigned amidst an investigation into whether he committed misconduct, Japanese media outlets are reporting.
According to the reports, the university has been investigating Shigeaki Kato and his group, affiliated with the Institute of Molecular and Cellular Biosciences, for scientific misconduct. The investigation was prompted by an outside whistleblower’s allegations in January about 24 of Kato’s papers. The whistleblower claimed that the papers manipulated and reused data improperly, and created a YouTube video to spread the word, as ScienceInsider reported earlier this year.
One of the 24 papers, Continue reading Endocrinologist Shigeaki Kato resigns amidst University of Tokyo misconduct investigation
Perhaps it’s appropriate given the Easter season, but we have learned that Naoki Mori, the Japanese cancer researcher who received a 10-year publishing ban from the American Society of Microbiology (ASM) for imagine manipulation, has published a new paper.
Mori, who was fired and then rehired by the University of the Ryukyus over the scandal, is listed as the senior author on the paper, “Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia,” which appears in the March issue of Biochimica et Biophysica Acta. The journal, an Elsevier title, is an umbrella for nine publications in the biosciences.
Two of Mori’s retracted articles appeared in the Elsevier journals Leukemia Research and Biochemical and Biophysical Research Communications. Continue reading Back in the saddle: After more than 30 retractions, Naoki Mori publishing again
Alirio Melendez, the former National University of Singapore researcher who has already retracted two papers in the midst of an investigation into about 70 of his publications, has had a third retracted a third.
Here’s the notice from the Journal of Cellular Physiology: Continue reading Third retraction arrives for Alirio Melendez, this one in the Journal of Cellular Physiology
Normally we’d make hay with the following notice in Acta Biochimica et Biophysica Sinica — separating the wheat from the chaff, Love and Death, and all that — but, well, it speaks for itself (sort of).
A group of researchers in China have retracted their 2011 paper on the biochemistry of chloroplast in wheat: Continue reading It “takes a long time to have these experiments redone,” so group retracts wheat paper after reader challenges
A partial retraction has joined the ten retractions and five corrections of Anil Potti’s papers, this one of a 2008 paper in Molecular Cancer Therapeutics. The move comes 14 months after the retraction of the Nature Medicine paper upon which much of the Molecular Cancer Therapeutics paper was based.
Here’s the notice: Continue reading A “retraction in part” for Anil Potti and colleagues, in Molecular Cancer Therapeutics